Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance
The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infection...
Gespeichert in:
Veröffentlicht in: | Antiviral therapy 2008-01, Vol.13 (3), p.461-466 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 466 |
---|---|
container_issue | 3 |
container_start_page | 461 |
container_title | Antiviral therapy |
container_volume | 13 |
creator | GÖHRING, Katharina MIKELER, Elfriede JAHN, Gerhard ROHDE, Frank HAMPRECHT, Klaus |
description | The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance.
The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses.
A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained.
We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis. |
doi_str_mv | 10.1177/135965350801300308 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21270068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21270068</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</originalsourceid><addsrcrecordid>eNplkE9v1DAQRy0EokvhC3BAvsAtMLaTOD6iVfkjrQSq6DmyJ-OtURJvbadSb3x0ErqCA6eRRu_3Do-x1wLeC6H1B6Ea0zaqgQ6EAlDQPWE7CTVUEpruKdttQLURF-xFzj8BZGcAnrML0TVa6hZ27Ne1PYWBZ5rC3WLnEoot4Z54IjtWJUzEv--vuY-Jl1viAxXCEuLMo-e3y2Rnjg8lTnS0Y7wPacn85mA0n5ZNE-fMMc6eUgrzkR_tjAH_cKs-h1zWB71kz7wdM70630t28-nqx_5Ldfj2-ev-46HCWstSCYemgQHRthpa2blWYdOh1hqMo9YbZR3V0lnnsPa1M62xA2lHqpaIxqtL9u7Re0rxbqFc-ilkpHG0M8Ul91JIDdB2KygfQUwx50S-P6Uw2fTQC-i37v3_3dfRm7N9cRMN_ybn0Cvw9gzYjHb0aYuR_3ISlFHGgPoNZS6Nxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21270068</pqid></control><display><type>article</type><title>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</title><source>MEDLINE</source><source>Sage Journals GOLD Open Access 2024</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>GÖHRING, Katharina ; MIKELER, Elfriede ; JAHN, Gerhard ; ROHDE, Frank ; HAMPRECHT, Klaus</creator><creatorcontrib>GÖHRING, Katharina ; MIKELER, Elfriede ; JAHN, Gerhard ; ROHDE, Frank ; HAMPRECHT, Klaus</creatorcontrib><description>The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance.
The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses.
A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained.
We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis.</description><identifier>ISSN: 1359-6535</identifier><identifier>EISSN: 2040-2058</identifier><identifier>DOI: 10.1177/135965350801300308</identifier><identifier>PMID: 18572760</identifier><language>eng</language><publisher>London: International Medical Press</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Cytomegalovirus - drug effects ; Cytomegalovirus - enzymology ; Cytomegalovirus - genetics ; Drug Resistance, Viral - genetics ; Ganciclovir - pharmacology ; Genotype ; Human cytomegalovirus ; Humans ; Medical sciences ; Mutation ; Pharmacology. Drug treatments ; Phenotype ; Phosphotransferases (Alcohol Group Acceptor) - genetics ; Polymerase Chain Reaction - methods ; Polymorphism, Restriction Fragment Length ; Reproducibility of Results ; Time Factors</subject><ispartof>Antiviral therapy, 2008-01, Vol.13 (3), p.461-466</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</citedby><cites>FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20393990$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18572760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GÖHRING, Katharina</creatorcontrib><creatorcontrib>MIKELER, Elfriede</creatorcontrib><creatorcontrib>JAHN, Gerhard</creatorcontrib><creatorcontrib>ROHDE, Frank</creatorcontrib><creatorcontrib>HAMPRECHT, Klaus</creatorcontrib><title>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</title><title>Antiviral therapy</title><addtitle>Antivir Ther</addtitle><description>The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance.
The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses.
A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained.
We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cytomegalovirus - drug effects</subject><subject>Cytomegalovirus - enzymology</subject><subject>Cytomegalovirus - genetics</subject><subject>Drug Resistance, Viral - genetics</subject><subject>Ganciclovir - pharmacology</subject><subject>Genotype</subject><subject>Human cytomegalovirus</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mutation</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Phosphotransferases (Alcohol Group Acceptor) - genetics</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Reproducibility of Results</subject><subject>Time Factors</subject><issn>1359-6535</issn><issn>2040-2058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkE9v1DAQRy0EokvhC3BAvsAtMLaTOD6iVfkjrQSq6DmyJ-OtURJvbadSb3x0ErqCA6eRRu_3Do-x1wLeC6H1B6Ea0zaqgQ6EAlDQPWE7CTVUEpruKdttQLURF-xFzj8BZGcAnrML0TVa6hZ27Ne1PYWBZ5rC3WLnEoot4Z54IjtWJUzEv--vuY-Jl1viAxXCEuLMo-e3y2Rnjg8lTnS0Y7wPacn85mA0n5ZNE-fMMc6eUgrzkR_tjAH_cKs-h1zWB71kz7wdM70630t28-nqx_5Ldfj2-ev-46HCWstSCYemgQHRthpa2blWYdOh1hqMo9YbZR3V0lnnsPa1M62xA2lHqpaIxqtL9u7Re0rxbqFc-ilkpHG0M8Ul91JIDdB2KygfQUwx50S-P6Uw2fTQC-i37v3_3dfRm7N9cRMN_ybn0Cvw9gzYjHb0aYuR_3ISlFHGgPoNZS6Nxw</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>GÖHRING, Katharina</creator><creator>MIKELER, Elfriede</creator><creator>JAHN, Gerhard</creator><creator>ROHDE, Frank</creator><creator>HAMPRECHT, Klaus</creator><general>International Medical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>20080101</creationdate><title>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</title><author>GÖHRING, Katharina ; MIKELER, Elfriede ; JAHN, Gerhard ; ROHDE, Frank ; HAMPRECHT, Klaus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cytomegalovirus - drug effects</topic><topic>Cytomegalovirus - enzymology</topic><topic>Cytomegalovirus - genetics</topic><topic>Drug Resistance, Viral - genetics</topic><topic>Ganciclovir - pharmacology</topic><topic>Genotype</topic><topic>Human cytomegalovirus</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mutation</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Phosphotransferases (Alcohol Group Acceptor) - genetics</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Reproducibility of Results</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GÖHRING, Katharina</creatorcontrib><creatorcontrib>MIKELER, Elfriede</creatorcontrib><creatorcontrib>JAHN, Gerhard</creatorcontrib><creatorcontrib>ROHDE, Frank</creatorcontrib><creatorcontrib>HAMPRECHT, Klaus</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Antiviral therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GÖHRING, Katharina</au><au>MIKELER, Elfriede</au><au>JAHN, Gerhard</au><au>ROHDE, Frank</au><au>HAMPRECHT, Klaus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</atitle><jtitle>Antiviral therapy</jtitle><addtitle>Antivir Ther</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>13</volume><issue>3</issue><spage>461</spage><epage>466</epage><pages>461-466</pages><issn>1359-6535</issn><eissn>2040-2058</eissn><abstract>The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance.
The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses.
A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained.
We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis.</abstract><cop>London</cop><pub>International Medical Press</pub><pmid>18572760</pmid><doi>10.1177/135965350801300308</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1359-6535 |
ispartof | Antiviral therapy, 2008-01, Vol.13 (3), p.461-466 |
issn | 1359-6535 2040-2058 |
language | eng |
recordid | cdi_proquest_miscellaneous_21270068 |
source | MEDLINE; Sage Journals GOLD Open Access 2024; EZB-FREE-00999 freely available EZB journals |
subjects | Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - pharmacology Biological and medical sciences Cytomegalovirus - drug effects Cytomegalovirus - enzymology Cytomegalovirus - genetics Drug Resistance, Viral - genetics Ganciclovir - pharmacology Genotype Human cytomegalovirus Humans Medical sciences Mutation Pharmacology. Drug treatments Phenotype Phosphotransferases (Alcohol Group Acceptor) - genetics Polymerase Chain Reaction - methods Polymorphism, Restriction Fragment Length Reproducibility of Results Time Factors |
title | Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T03%3A08%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rapid%20semiquantitative%20real-time%20PCR%20for%20the%20detection%20of%20human%20cytomegalovirus%20UL97%20mutations%20conferring%20ganciclovir%20resistance&rft.jtitle=Antiviral%20therapy&rft.au=G%C3%96HRING,%20Katharina&rft.date=2008-01-01&rft.volume=13&rft.issue=3&rft.spage=461&rft.epage=466&rft.pages=461-466&rft.issn=1359-6535&rft.eissn=2040-2058&rft_id=info:doi/10.1177/135965350801300308&rft_dat=%3Cproquest_cross%3E21270068%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21270068&rft_id=info:pmid/18572760&rfr_iscdi=true |